Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines

1 May 2023

Abstract excerpt

Abstract Purpose Tumor Treating Fields (TTFields) are electric fields that disrupt cellular processes critical for cancer cell viability and tumor progression, ultimately leading to cell death. TTFields therapy is approved for treatment of newly-diagnosed glioblastoma (GBM) concurrent with maintenance temozolomide (TMZ). Recently, the benefit of TMZ in combination with lomustine (CCNU) was demonstrated in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Metastases and Treatment
Share to Glioma Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 37131108
DOI: 10.1007/s11060-023-04308-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell linesPMID 37131108Read ↗

The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cellsSemantic proximity Read ↗

Gene expression profiling of glioblastoma cell lines depending on TP53 status after tumor-treating fields (TTFields) treatmentSemantic proximity Read ↗

Experience about Chemoradiation treatment with or without Concurrent Tumor-Treating Fields (TTFields) in Newly Diagnosed Glioblastoma (GBM) Patients in ChinaSemantic proximity Read ↗

The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields)Semantic proximity Read ↗

“Tumor Treating Fields” delivered via electromagnetic induction have varied effects across glioma cell lines and electric field amplitudesSemantic proximity Read ↗

Treatment with Tumor-Treating Fields (TTFields) Suppresses Intercellular Tunneling Nanotube Formation <i>In Vitro</i> and Upregulates Immuno-Oncologic Biomarkers <i>In Vivo</i> in Malignant MesotheliomaSemantic proximity Read ↗

PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomideSemantic proximity Read ↗

DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cellsSemantic proximity Read ↗

PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma.Semantic proximity Read ↗

Ultrasound Activated Nano TiO2 Loaded With Temozolomide Paves the Way for Resection of Chemo-resistant Glioblastoma MultiformeSemantic proximity Read ↗

Enhancing Therapeutic Approaches in Glioblastoma with Prooxidant Treatments and Synergistic Combinations: <em>In Vitro</em> Experience of Doxorubicin and Photodynamic TherapySemantic proximity Read ↗

Mechanisms of reversal of temozolomide resistance in glioblastoma through downregulation of BCL3 by the Tumor Electric Field TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.